Researchers from Kennedy Krieger Institute, University of Rochester Medicine, and five other Institutions released a new publication detailing how the use of master protocol trials could change the future of rare disease research. Using master protocol trials in researching rare conditions could decrease costs, improve testing efficiency and capacity, and expedite the delivery of treatments to those facing a rare disease diagnosis.